Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7215225 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL6359411 | 1.00 | — | — | |
| SCHEMBL28822656 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL7847798 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL11338439 | 0.71 | — | — | |
| SCHEMBL29795443 | 0.71 | — | — | |
| SCHEMBL4049251 | 0.71 | — | — | |
| SCHEMBL4403656 | 0.71 | — | — | |
| SCHEMBL9821880 | 0.71 | — | — | |
| Ammonia Solution, Strong SCHEMBL9800883 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3837241-B1 | FLUORO SS-CARBOLINE COMPOUNDS FOR THE TREATMENT OF BONE HOMEOSTASIS | OSSIFI THERAPEUTICS LLC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20250325556-A1 | COMPOSITIONS FOR LOCAL BONE FORMATION | OSSIFI THERAPEUTICS LLC (US) | 2025-10-23 | — | — | US | disclosed |
| US-12324809-B2 | Fluoro beta-carboline compounds | OSSIFI THERAPEUTICS LLC (US) | 2025-06-10 | — | — | US | disclosed |
| US-20250025472-A1 | FLUORO BETA-CARBOLINE COMPOUNDS | OSSIFI THERAPEUTICS LLC | 2025-01-23 | — | — | US | disclosed |
| US-12195461-B2 | Pyrrolo-dipyridine compounds | OSSIFI THERAPEUTICS LLC (US) | 2025-01-14 | — | — | US | disclosed |
| EP-3836923-B1 | PYRROLO - DIPYRIDINE COMPOUNDS FOR THE TREATMENT OF BONE LOSS | OSSIFI THERAPEUTICS LLC (US) | 2024-10-16 | — | — | EP | disclosed |
| EP-4436572-A1 | COMPOSITIONS FOR LOCAL BONE FORMATION | Ossifi Therapeutics Llc (US) | 2024-10-02 | — | — | EP | disclosed |
| US-11903949-B2 | Fluoro beta-carboline compounds | OSSIFI THERAPEUTICS LLC (US) | 2024-02-20 | — | — | US | disclosed |
| EP-3915987-B1 | ALKYL-AMINE HARMINE DERIVATIVES FOR PROMOTING BONE GROWTH | OSTEOQC INC (CA) | 2023-12-13 | — | — | EP | disclosed |
| US-20230277545-A1 | COMPOSITIONS FOR LOCAL BONE FORMATION | OSSIFI THERAPEUTICS LLC | 2023-09-07 | — | — | US | disclosed |
| US-20230203036-A1 | PYRROLO - DIPYRIDINE COMPOUNDS | OSSIFI THERAPEUTICS LLC | 2023-06-29 | — | — | US | disclosed |
| WO-2023097250-A1 | COMPOSITIONS FOR LOCAL BONE FORMATION | OSSIFI-ML LLC (US) | 2023-06-01 | — | — | WO | disclosed |
| US-11655250-B2 | Pyrrolo-dipyridine compounds | OSTEOQC INC. (CA) | 2023-05-23 | — | — | US | disclosed |
| US-11267814-B2 | Compounds for bone growth | OsteoQC, Inc. | 2022-03-08 | — | — | US | disclosed |
| US-20220024922-A1 | PYRROLO - DIPYRIDINE COMPOUNDS | OSSIFI THERAPEUTICS LLC | 2022-01-27 | — | — | US | disclosed |